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Abstract 
Polychlorinated biphenyls (PCBs) as well as dioxins (polychlorinated ibenzo-p-dioxins (PCDDs) and 
dibenzofurans (PCDFs)) are potentially hazardous compounds in the environment for human beings. 
In order to investigate PCB and dioxin exposure of Dutch women and their neonates, levels were examined in 
418 mother-infant pairs. Four non-planar PCB congener levels (PCB 118, 138, 153 and 180) were measured in 
maternal plasma nd in umbilical cord plasma. The 209 mothers who breast-fed their infants collected human milk 
samples for the analysis of seventeen 2,3,7,8-substituted PCDD and PCDF congener levels, three planar PCB and 
twenty-three non-planar PCB congener levels. 
The dioxin and planar PCB levels we measured in human milk (mean 30 respectively 16 pg TEQ/g fat), belong 
to the highest background levels analysed all over the world but they are in the normal range for highly 
industrialised, densely populated countries in Western Europe. 
Correlation coefficients between PCB 118, 138, 153 and 180 congener levels in maternal plasma nd PCB levels 
in cord plasma or PCB and dioxin levels in human milk are highly significant. However, the 95 % predictive 
interval is too wide to predict accurately the PCB and dioxin levels to which an individual infant is exposed in 
utero or postnatally by breast-feeding, from the PCB levels in maternal plasma. 
Introduction 
Polychlorinated biphenyls (PCBs) are a compilation of 209 possible congeners with different chlorine substitutions. 
Within the group of PCB congeners different subgroups can be defined (Figure I). The planar PCBs have no 
chlorine atom on the ortho position of the biphenyl ring structure and they resemble closely the dioxins because 
of their planar structure. The mono-ortho PCBs have one chlorine atom on the ortho position and the di-ortho 
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Figure l Molecular ~ructuresofPCBs, PCDDsandPCDFs 
m o 
(C l~~ (cl)m 
(CI)m 
Polychlorinated biphenyls 
(PCBs) 
Polychlorinated dibenzo-p-dioxins 
(PCDDs) 
(C I )~CI ) rn  
Polychlorinated dibenzofurans 
(PCDFs) 
* O=Ortho, M=Meta, P=Para position. 
PCBs have two chlorine atoms on the ortho position. All three kinds of PCB structures are also chlorinated in 
both para and at least two meta positions. Having more chlorine atoms on the ortho positions the coplanadty 
between the two phenyl rings is reduced and thus the toxicity of the congener. 
The degree of biphenyl chlorination also alters the properties and applications of commercial mixtures. 1 After the 
detection of ubiquitous levels of PCBs in the environment, the production and use of these compounds were 
banned in the late 1970s. However, large amounts of PCBs were dumped so that land, water and especially sludge 
can still be highly polluted and thus form a source of contamination foranimals and humans. 
Polychiorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs), summarized as dioxins, are tricyclic 
aromatic ompounds. Since the number of chlorine atoms can vary between 1 and 8, there are potentially 75 
different PCDD and 135 PCDF congeners. They are mainly formed as by-products during the combustion of 
municipal and hazardous waste and during the manufacturing of organochlorine chemicals. 2 
Higher chlorinated PCB and dioxin congeners are more abundant in most biotic samples because they are highly 
lipophilic, chemically stable and accumulate in the food chain. For humans the main sources of exposure to these 
compounds are dairy products, meat and fish. 3 PCBs, PCDDs and PCDFs may produce awide spectrum of toxic 
effects in animals and humans. 4'° 
In this paper we wish to answer the following questions: what are the PCB levels in maternal nd cord plasma, 
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and what are the PCB, PCDD and PCDF levels in human milk of Dutch women? Is there a decline in PCB or 
dioxin levels in human milk samples of the second and sixth week after delivery7 As dioxin measurements are 
time-consuming, expensive and require large volumes of blood (100-200 ml), we investigated if one of the more 
easily measurable PCB congener levels in maternal plasma could predict he PCB and dioxin exposure of the 
developing fetus and breast-fed infant, 
This study is part of the Dutch PCB/Dioxin study, a prospective longitudinal study on possible adverse health 
effects of these pollutants for human beings. 
Methods 
The study group consisted of 418 healthy mother-infant pairs recruited between June 1990 and June 1992. Two 
hundred and seven pairs have been living in Rotterdam and the surrounding area, which is a highly industrialised 
region in the western part of the Netherlands. The other 211 pairs have been living in Groningen and the 
surrounding area, which is a semi-urban region in the north. Women were asked by their obstetrician or midwife 
to volunteer for the study. During the last month of pregnancy, mothers were visited at home for an explanation 
of the study protocol. 
In order to establish an optimal study population, only infants born at term (37 to 42 weeks of gestation) without 
congenital nomalies or diseases were included. Pregnancy and delivery had to be passed without overt signs of 
serious illness or complications. All mothers and infants were of the Caucasian race. In order to study the effects 
of postnatal dioxin and PCB exposure a group of pregnant women was selected of whom 50% had the intention 
to breast-feed their infants and the other 50% to give formula feeding. Formula countains negligible levels of 
dioxins and PCBs. The mothers who breast-fed their infants (n=209) had to do so for at least 6 weeks. The 
bottle-fed infants (n=209) received formula milk from one batch during 7 months. 
A blood sample was taken from the mothers in the last month of their pregnancy (36th to 40th week) for the 
measurement of PCB congener levels 2,3',4,4' ,5-pentachlorobiphenyl (PCB I 18), 2,2'3,4,4' ,5'-hexachlorobiphe- 
nyl (PCB 138), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153)and 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB 
180). 11 A blood sample of the umbilical cord was taken to measure the same PCB congener levels as an indication 
of prenatal exposure. Blood was collected in a vacuum system EDTA-tube, transported in a cooling-pall, and 
centrifuged within 24 hours during 15 minutes at 3000 rpm; plasma was stored at -20 °C until analysis. 
In the second and sixth week after delivery, the mothers collected a 24-hour epresentative sample of breastmilk 
by collecting before each feeding as much milk as possible from both breasts with a vacuum pump. An aliquot 
of ten percent of each sample was pooled and stored in the refrigerator, the remainder was given to the infants 
in a bottle. After 24 hours the milk was stored at -20 °C until analysis. 
PCB congeners in plasma were measured by gas chromatography with electron capture detection (GC-ECD). 12 
Plasma was denaturated with methanol and the chlorinated biphenyl congeners were isolated from the plasma with 
hexane-ethyl ether. The extract was dried over sodium sulphate, concentrated and purified by chromatography 
over basic alumina deactivated with 10% water. The analysis was carried out on two capillary columns of 
different polarity. The limit of determination for the four congeners was 0.01 ng/g plasma. The recovery of the 
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chlorinated biphenyl congeners added to the plasma before extraction and determined as described above, was 
> 95 %. In each series a chemical blank, and a control sample have been analysed to assure the quality. 
The human milk samples were analysed for the 17 most abundant 2,3,7,8-substituted PCDD and PCDF congeners 
and three planar PCB congeners (3,3',4,4'-tetrachlorobiphenyl (PCB 77), 3,3',4,4',5-pentachlorobiphenyl (PCB 
126), and 3,3' ,4,4' ,5,5'-hexachlorobiphenyl (PCB 169)) by gas chromatography-high-resolution mass pectrometry 
(GC-HRMS). ~3 Twenty-three non-planar PCB congeners (IUPAC no. 28, 52, 66, 70, 99, 101, 105, 118, 128, 
137, 138, 141, 151, 153, 156, 170, 177, 180, 183, 187, 194, 195 and 202) N were measured by GC-ECD. 14 
To express the toxic potency of the mixture of dioxins and PCBs in breastmilk samples, the international toxic 
equivalence factor (I-TEF) approach ~5 was used for the PCDDs and PCDFs, and the WHO 1993 approach for the 
PCBs. 16 A TEF value was assigned to the dioxin and dioxin-like PCB congeners which represents heir relative 
toxic potency towards 2,3,7,8-TCDD, the most toxic dioxin congener which TEF value is one. By multiplying 
the concentration (pg/g milkfat) and TEF value, the toxic equivalent (TEQ) of each congener was calculated (pg 
TEQ/g milkfat). By adding up the TEQs of all congeners the total-TEQ value was obtained. The TEQ-sum of 
the 17 dioxin congeners yielded adioxin-TEQ, the three planar PCB (77, 126, 169), three mono-ortho PCB (105, 
118, 156) and two di-ortho PCB congeners (170, 180) revealed a planar, mono-ortho and di-ortho PCB-TEQ 
respectively. The other PCB congeners did not receive a TEF value because they have negligible dioxin-like 
activity. The study protocol had been approved by the medical ethical committee of the University Hospital 
Rotterdam/Sophia Children's Hospital and the University of Groningen. Informed consent had been given by the 
parents. 
Data analysis was performed by means of the statistical soft-ware package SPSS/PC. Means, medians, ranges and 
standard eviations are reported in terms of original distributions. Spearman rank correlation coefficients were 
measured between the different congener levels in plasma and human milk. A 95% interval for predicting the 
total-TEQ in human milk from the PCB 153 level in maternal plasma for an individual subject, was calculated 
after log transformation f the variables. The paired Student's t test was used to determine differences in mean 
PCB and dioxin levels in paired human milk samples of the second and sixth week, after log transformation. 
Results 
The mean, median and range of PCB 118, 138, 153 and 180 congener levels in maternal and cord plasma re 
summarized in Table I. Three maternal plasma samples missed, 36 cord plasma samples missed for the PCB 138, 
153 and 180 analysis and 45 for the PCB 118 analysis, due to organization failure. 
The mean, median, range and available TEQ values of all PCDD, PCDF and PCB congener levels in human milk 
samples of the second week after birth are summarized in Table II and III. Representative PCDD, PCDF and 
planar PCB congener levels are presented of 176 respectively 194 human milk samples and non-planar PCB 
congener levels of 195 samples. 
Spearman rank correlation coefficients between levels of the four different non-planar PCB congeners (118, 138, 
153, 180) within one biological sample such as maternal plasma, cord plasma or human milk are all highly 
significant and vary from 0.71 to 0.98. However, the correlation coefficients in human milk between all other 
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PCB and dioxin congener levels vary considerably from -0.16 to 0.85. 
Table I Mean, median and range of PCB 118, 138, 153 and 180 levels (ng/g plasma) in maternal and 
cord plasma. 
PCB 118 PCB 138 PCB 153 PCB 180 
Maternal plasma 
n 415 415 415 415 
mean 0.16 0.60 0.91 0.54 
median 0.15 0.56 0.84 0.50 
range 0.02-0.60 0.13-1.60 0.18-2.50 0.08-3.10 
Cord plasma 
n 373 382 382 382 
mean 0.04 0.13 0.18 0.10 
median 0.04 0.11 0.15 0.08 
range 0.01-0.16 0.01-0.59 0.02-0.85 0.01-0.76 
Relations between PCB and dioxin congener levels in different biological samples were also analysed. The 
correlation coefficients between levels of the four PCB congeners 118, 138. 153 and 180 in maternal plasma nd 
cord plasma vary from 0.52 to 0.74. In Table IV Spearman rank correlation coefficients between these four PCB 
congener levels in maternal plasma nd human milk are presented. The correlation coefficients are all significant, 
the corresponding congeners having the highest correlations. In Table V Spearman rank correlation coefficients 
between these four PCB congener levels in human milk and dioxin- and PCB-TEQ levels in human milk have been 
summarized. The correlation coefficients are highly significant. In Table VI Spearman rank correlation coefficients 
between these PCB congener levels in maternal plasma nd dioxin-TEQ and PCB-TEQ levels in human milk are 
summarized. The correlation coefficients are less compared to the coefficients in Table V. In Figure II the 95% 
confidence interval for the regression line between the PCB 153 level in maternal plasma nd the total-TEQ level 
in human milk is shown as well as the 95% predictive interval for the total-TEQ from the PCB 153 level for an 
individual subject. For instance, if the PCB 153 level in maternal plasma would be equal to the mean, 0.91 ng/g 
plasma, the upper limit of the 95 % predictive interval of the total-TEQ level in her breastmilk would be 100.0 
pg TEQ/g fat, the lower limit 39.8 pg TEQ/g fat. Since the predictive interval is wide, it is impossible in this way 
to predict accurately the PCB and dioxin levels to which an individual fetus or breast-fed infant is exposed. 
Paired human milk samples collected in the second and sixth week after birth were analyzed for dioxin- and PCB- 
TEQ levels. Results are presented in Table VII. The Student's t test for paired samples howed no significant 
decrease in mean dioxin-, planar PCB- or total-TEQ level over a four weeks period. However the mean mono- 
ortho and di-ortho PCB-TEQ level were significantly decreased in this period. 
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Table II Mean, median and range (pg/g fat) and mean TEQ (pg TEQ/g fat) of PCDD, PCDF (N = 176) 
and planar PCB (N = 194) levels in human milk samples of the second week after birth. 
PCDD'S IUPAC TEF mean median range TEQ 
2,3,7,8-TCDD 48 1 4.0 3.6 0.03-15.8 4.0 
1,2,3,7,8-PECDD 54 0.5 10.6 10.2 0.1-30.1 5.3 
1,2,3,4,7,8-HXCDD 66 0.1 8.7 8.7 0.04-28.4 0.9 
1,2,3,6,7,8-HXCDD 67 0.1 47.4 45.8 18.7-131.8 4.7 
1,2,3,7,8,9-HXCDD 70 0.1 6.7 6.7 0.04-21.0 0.7 
1,2,3,4,6,7,8-HPCDD 73 0.01 63.2 58.1 0.1-178.4 0.6 
1,2,3,4,6,7,8,9-OCDD 75 0.001 799.6 670.4 224.2-3113.6 0.8 
PCDF'S IUPAC TEF mean median range TEQ 
2,3,7,8-TCDF 83 0.1 0.8 0.7 0.02-3.2 0.08 
1,2,3,7,8-PECDF 94 0.05 0.3 0.1 0.02-4.7 0.01 
2,3,4,7,8-PECDF 114 0.5 22.7 21.6 8.4-55.0 11.3 
1,2,3,4,7,8-HXCDF 118 0.1 6.6 6.4 0.1-15.3 0.7 
1,2,3,6,7,8-HXCDF 121 0.1 5.7 5.5 0.1-12.5 0.6 
2,3,4,6,7,8-HXCDF 130 0.1 3.6 3.0 0.04-16.9 0.4 
1,2,3,7,8,9-HXCDF 124 0.1 0.3 0.1 0.02-21.5 0.03 
1,2,3,4,6,7,8-HPCDF 131 0.01 7.9 6.3 0.1-72.3 0.08 
1,2,3,4,7,8,9-HPCDF 134 0.01 0.2 0.2 0.05-1.8 0.0 
1,2,3,4,6,7,8,9-OCDF 135 0.001 2.2 0.4 0.1-215.5 0.0 
DIOXIN-TEQ 30.2 
PLANAR PCB'S IUPAC TEF mean median range TEQ 
3,3',4,4'-PCB 77 0.0005 19.3 14.8 3.7-143.2 0.01 
3,3',4,4',5-PCB 126 0.1 152.0 137.5 39.4-443.9 15.2 
3,3' ,4,4' ,5,5'-PCB 169 0.01 84.3 79.5 33.2-282.9 0.8 
PLANAR PCB-TEQ 16.0 
IUPAC = International Union of Pure and Applied Chemistry 
TEF = Toxic Equivalence Factor (I-TEFs for dioxins ~5, WHO '93 TEFs for PCBs ~6) 
TEQ = Toxic Equivalent 
Table III 
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Mean, median and range (ng/g fat) and mean TEQ (pg TEQ/g fat) of non-planar PCB levels 
in human milk samples of the second week after birth. N = 195. 
IUPAC TEF mean median range TEQ 
2,4,4' 28 12.1 5.8 0.2-188.6 
2,2',5,5' 52 2.6 1.5 0.2-32.7 
2,3',4,4' 66 11.6 9.4 0.4-79.6 
2,3,'4',5 70 18.5 17.4 0.5-54.2 
2,2',4,4',5 99 19.7 18.1 1.4-54.1 
2,2',4,5,5' 101 1.5 1.1 0.2-10.0 
2,3,3',4,4' 105" 0.0001 9.4 8.7 0.4-22.9 
2,3' ,4,4',5 118* 0.0001 35.5 32.7 9.7-94.0 
2,2',3,3',4,4' 128 4.0 3.7 0.4-16.1 
2,2',3,4,4',5 137 16.8 13.4 1.4-174.6 
2,2',3,4,4',5' 138 129.9 124.2 43.8-314.3 
2,3,4,5,2'5' 141 1.1 0.8 0.3-7.1 
2,2',3,5,5',6 151 0.9 0.8 0.2.-7.5 
2,2',4,4',5,5' 153 186.3 174.7 59.9-475.7 
2,3,3',4,4',5 156" 0.0005 21.0 20.1 2.9-78.0 
2,2',3,3',4,4',5 170"* 0.0001 37.1 35.4 11.4-219.9 
2,2',3,3',4',5,6 177 6.3 5.9 0.4-22.4 
2,2',3,4,4',5,5' 180"* 0.00001 76.8 71.3 2.5-418.8 
2,2',3,4,4',5',6 183 12.2 11.5 2.9-34.6 
2,2' ,3,4' ,5,5',6 187 20.0 17.9 2.9-103.8 
2,2',3,3',4,4',5,5' 194 8.6 7.8 0.6-74.2 
2,2' ,3,3' ,4,4' ,5,6 195 2.9 2.7 0.5-15.5 
2,2',3,3',5,5',6,6' 202 0.9 0.7 0.2-8.6 
Mono-ortho PCB-TEQ 
Di-ortho PCB-TEQ 
0.9 
3.6 
10.5 
3.7 
0.8 
15.0 
4.5 
IUPAC = International Union of Pure and Applied Chemistry 
TEF = Toxic Equivalence Factor (WHO '93 TEFs for PCBs 16) 
TEQ = Toxic Equivalent 
* = mono-ortho PCB 
** = di-ortho PCB 
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Table IV Spearman rank correlation coefficients between PCB congener levels in human milk (ng/g 
fat) and PCB congener levels in maternal plasma (ng/g). All correlations have a significance of p_<0.0001. 
N=193. 
Maternal plasma 
Human milk 
PCB 118 PCB 138 PCB 153 PCB 180 
PCB 118 0.77 0.69 0.64 0.51 
PCB 138 0.63 0.79 0.76 0.67 
PCB 153 0.62 0.78 0.77 0.72 
PCB 180 0.48 0.63 0.66 0.70 
Table V Spearman rank correlation coefficients between PCB congener levels in human milk (ng/g fat) 
and dioxin and PCB levels in human milk (pg TEQ/g fat). All correlations have a significance of p < 0.0001. 
Human milk 
Human milk 
dioxins planar PCBs mono-ortho di-ortho Total TEQ 
PCBs PCBs 
n = 168 n = 186 n = 195 n = 195 n = 168 
PCB 118 0.69 0.81 0.85 0.64 0.84 
PCB 138 0.77 0.61 0.93 0.86 0.85 
PCB 153 0.78 0.59 0.94 0.90 0.86 
PCB 180 0.70 0.47 0.80 0.91 0.73 
(I-TEFs for dioxins ts, WHO '93 TEFs for PCBs ~6) 
Table VI Spearman rank correlation coefficients between PCB congener levels in maternal plasma (ng/g) 
and dioxin and PCB levels in human milk (pg TEQ/g fat). All correlations have a significance of p _ 0.0001. 
Human milk 
Maternal plasma dioxins planar PCBs mono-ortho PCBs di-ortho PCBs Total TEQ 
n=174 n --- 192 n = 193 n = 193 n = 166 
PCB 118 0.64 0.70 0.64 0.51 0.71 
PCB 138 0.65 0.51 0.75 0.69 0.71 
PCB 153 0.67 0.50 0.75 0.72 0.71 
PCB 180 0.63 0.42 0.70 0.76 0.66 
(I-TEFs for dioxins tS, WHO '93 TEFs for PCBs 16) 
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Figure II 95 % Predictive interval of the totaI-TEQ level in human milk from the PCB 153 level in 
maternal plasma. 
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Table VII Mean dioxin, planar PCB, mono-ortho PCB, di-ortho PCB and total TEQ levels 
(pg TEQ/g fat) in human milk samples of the second and sixth week after delivery. 
Sample I Sample II P* corr. coeff.** N 
mean s.d. mean s.d. 
dioxins 34.4 ___ 12.4 31.8 _ 10.3 0.07 0.88 27 
planar PCBs 16.7 _ 8.0 16.7 + 7.7 0.91 0.67 44 
mono-ortho PCBs 15.2 _+ 5.8 14.3 _ 5.4 0.002 0.85 180 
di-ortho PCBs 4.5 _ 2.4 4.3 + 2.3 0.001 0.92 180 
total TEQ 72.3 _ 31.3 66.0 + 23.9 0.10 0.94 19 
* = Paired Student's t test, for log normalized values 
** = Correlation coefficient between the paired milk samples of one woman 
s.d. = standard eviation 
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Discussion 
We measured 17 dioxin and 26 PCB congener levels in human milk and 4 PCB congener levels in mammal and 
cord plasma. The mean dioxin-TEQ level (30 pg TEQ/g fat) is elevated compared to dioxin background levels 
in the Scandinavian countries (20 pg TEQ/g fat), Spain (13 pg TEQ/g fat) and the United States (17 pg TEQ/g 
fat). However the dioxin and PCB levels found in this study are comparable to the levels in other highly 
industrialised, densely populated countries in Western Europe such as Belgium, The United Kingdom and the 
Federal Republic of Germany. t7In the Netherlands the National Institute of Public Health and Environmental 
Protection (RIVM), measured PCDD, PCDF and PCB congener levels in human milk, in a WHO coordinated 
international study} 8In 1983 only PCB congener levels (IUPAC no. 28, 52, 101, 118, 153, 138, 180 and 194) 
were measured. In 1988 both PCBs and dioxins were measured. The PCB levels tended to decrease over the 5 
years period, as is the tendency all over the world. The median PCB congener levels we measured from 1990 to 
1992 are somewhat higher (PCB 138 and 153) or similar (PCB 118, 180 and 194) to the results the RIVM 
presented over the year 1983. This may be due to differences in analytical methods. 
PCB congener levels in maternal plasma re about five times higher compared to the levels in umbilical cord 
plasma. When expressed on a lipid base the levels are comparable tg, because PCBs are highly bound to lipids 
which contents in cord blood are low compared to maternal blood? °'2j 
The total-TEQ value and the contribution of individual dioxin and PCB congener levels to the TEQ value, depend 
on the TEF values used. According to the model we used, the dioxins contribute for 46%, the planar PCBs for 
24%, the mono-ortho PCBs for 23% and the di-ortho PCBs for 7% to the total-TEQ value (65.2 pg TEQ/g fat). 
Although the mono-ortho and di-ortbo PCBs have low TEFs, they can contribute considerably to the total-TEQ 
because of their high concentrations i  human milk. 
Correlation coefficients between the non-planar PCB congener levels (PCB 118, 138, 153 and 180) in maternal 
plasma, cord plasma nd human milk are quite high within one biological sample as plasma or human milk (0.71 
to 0.98), as well as between different biological samples. However, correlation coefficients between other PCB 
and dioxin congener levels in human milk differ considerably. One explanation for this wide range in correlation 
coefficients could be that different congeners have different half-lives. Secondly, due to limitations of 
determination, levels of some congeners in plasma s well as in human milk might be less accurate. Finally, 
correlation coefficients between on-planar PCB levels in maternal plasma nd dioxin- or PCB-TEQ levels in 
human milk are lower compared to the correlation coefficients between the same non-planar PCB congener levels 
in human milk and the TEQ levels in human milk. Levels in plasma are detected in ng/g plasma while levels in 
human milk are expressed as ng/g fat. However, when we correlated the PCB plasma levels with the TEQ levels 
in human milk on product base (ng/g milk), the correlation coefficients were lower. Since new fat is produced 
in the breast, plasma nd milk might be different pools for PCB and dioxin congeners. 
We found a decline in mono-ortho and di-ortho PCB-TEQ levels in human milk over a 4 weeks period. However, 
the dioxin-, planar PCB- and total-TEQ levels did not change in this period. Fiirst 22 and Nor6n ~3 did report a 
decline in dioxin levels over a longer period of breast-feeding. 
Non-planar PCB levels in maternal plasma re relatively easy and cheap to analyse instead of dioxin and PCB 
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levels in human milk, which are time-consuming, expensive measurements. Moreover it is easier to collect a blood 
sample than a 24-hour epresentative human milk sample which is an onerous task for the mothers who collect 
the milk. Our results demonstrate hat non-planar PCB analysis in maternal plasma during pregnancy or even 
before conception can give an indication about in utero and postnatal breast-feeding exposure to PCDDs, PCDFs 
and PCBs, but the 95% predictive interval for an individual infant is wide. 
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